102 related articles for article (PubMed ID: 10210639)
1. Human insulin receptor and insulin signaling proteins in hepatic disease.
Spector SA; Olson ET; Gumbs AA; Friess H; Büchler MW; Seymour NE
J Surg Res; 1999 May; 83(1):32-5. PubMed ID: 10210639
[TBL] [Abstract][Full Text] [Related]
2. Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinase-dependent signalling.
Ahmed Z; Pillay TS
Biochem J; 2003 Apr; 371(Pt 2):405-12. PubMed ID: 12521378
[TBL] [Abstract][Full Text] [Related]
3. Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2-SOS complex in insulin receptor signaling.
Najib S; Sánchez-Margalet V
J Cell Biochem; 2002; 86(1):99-106. PubMed ID: 12112020
[TBL] [Abstract][Full Text] [Related]
4. Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes.
Tanaka S; Mohr L; Schmidt EV; Sugimachi K; Wands JR
Hepatology; 1997 Sep; 26(3):598-604. PubMed ID: 9303488
[TBL] [Abstract][Full Text] [Related]
5. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
de la Monte SM; Tamaki S; Cantarini MC; Ince N; Wiedmann M; Carter JJ; Lahousse SA; Califano S; Maeda T; Ueno T; D'Errico A; Trevisani F; Wands JR
J Hepatol; 2006 May; 44(5):971-83. PubMed ID: 16564107
[TBL] [Abstract][Full Text] [Related]
6. Insulin receptor substrate-4 signaling in quiescent rat hepatocytes and in regenerating rat liver.
Escribano O; Fernández-Moreno MD; Zueco JA; Menor C; Fueyo J; Ropero RM; Diaz-Laviada I; Román ID; Guijarro LG
Hepatology; 2003 Jun; 37(6):1461-9. PubMed ID: 12774026
[TBL] [Abstract][Full Text] [Related]
7. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
van der Geer P; Wiley S; Pawson T
Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
[TBL] [Abstract][Full Text] [Related]
9. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M
Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
[TBL] [Abstract][Full Text] [Related]
10. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.
Cantarini MC; de la Monte SM; Pang M; Tong M; D'Errico A; Trevisani F; Wands JR
Hepatology; 2006 Aug; 44(2):446-57. PubMed ID: 16871543
[TBL] [Abstract][Full Text] [Related]
11. N-3 polyunsaturated fatty acids prevent the defect of insulin receptor signaling in muscle.
Taouis M; Dagou C; Ster C; Durand G; Pinault M; Delarue J
Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E664-71. PubMed ID: 11832371
[TBL] [Abstract][Full Text] [Related]
12. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
13. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
[TBL] [Abstract][Full Text] [Related]
14. Human growth factor receptor bound 14 binds the activated insulin receptor and alters the insulin-stimulated tyrosine phosphorylation levels of multiple proteins.
Hemming R; Agatep R; Badiani K; Wyant K; Arthur G; Gietz RD; Triggs-Raine B
Biochem Cell Biol; 2001; 79(1):21-32. PubMed ID: 11235915
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional characterization of insulin receptor substrate proteins and the molecular mechanisms of their interaction with insulin superfamily tyrosine kinase receptors and effector proteins.
Shpakov AO; Pertseva MN
Membr Cell Biol; 2000; 13(4):455-84. PubMed ID: 10926366
[TBL] [Abstract][Full Text] [Related]
16. The gene structure of the human growth factor bound protein GRB2.
Bochmann H; Gehrisch S; Jaross W
Genomics; 1999 Mar; 56(2):203-7. PubMed ID: 10051406
[TBL] [Abstract][Full Text] [Related]
17. Differential gene expression of insulin receptor isoforms A and B and insulin receptor substrates 1, 2 and 3 in rat tissues: modulation by aging and differentiation in rat adipose tissue.
Serrano R; Villar M; Martínez C; Carrascosa JM; Gallardo N; Andrés A
J Mol Endocrinol; 2005 Feb; 34(1):153-61. PubMed ID: 15691885
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of the insulin receptor and type I insulin-like growth factor receptor are early events in hepatocarcinogenesis.
Aleem E; Nehrbass D; Klimek F; Mayer D; Bannasch P
Toxicol Pathol; 2011 Apr; 39(3):524-43. PubMed ID: 21411721
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis.
Nehrbass D; Klimek F; Bannasch P
Am J Pathol; 1998 Feb; 152(2):341-5. PubMed ID: 9466558
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of insulin receptor substrate-1 in human pancreatic cancer.
Bergmann U; Funatomi H; Kornmann M; Beger HG; Korc M
Biochem Biophys Res Commun; 1996 Mar; 220(3):886-90. PubMed ID: 8607861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
